KRRO

KRRO

USD

Korro Bio Inc. Common Stock

$13.830+0.530 (3.985%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$13.300

High

$14.260

Low

$13.300

Volume

0.13M

Company Fundamentals

Market Cap

129.9M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.14M

Exchange

NCM

Currency

USD

52-Week Range

Low $10.29Current $13.830High $98

Related News

GlobeNewswire

Korro to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (NASDAQ:KRRO) today announced that members of management will participate in the following upcoming investor conferences: 2025 RBC Capital

View more
Korro to Participate in Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Korro Bio, Lowers Price Target to $100

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio with a Buy and lowers the price target from $115 to $100.

View more
HC Wainwright & Co. Maintains Buy on Korro Bio, Lowers Price Target to $100
GlobeNewswire

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

—Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025 —Streamlining operations and focusing on delivering potential value

View more
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
Analyst Upgrades

Cantor Fitzgerald Initiates Coverage On Korro Bio with Overweight Rating, Announces Price Target of $74

Cantor Fitzgerald analyst Steven Seedhouse initiates coverage on Korro Bio with a Overweight rating and announces Price Target of $74.

View more
Cantor Fitzgerald Initiates Coverage On Korro Bio with Overweight Rating, Announces Price Target of $74